Caregiver Resthelp and hope for the one doing the caring
Dementia
Display
Tool · printable

Doctor-Visit Prep

The short answer
  • Bring three things, and the visit changes. What they are.
  • Say when it started and how fast. "New in the last two weeks" means investigate. "Slowly over six months" means progression. That one distinction drives most of the visit.
  • Ask for a medicine review by name. Nobody schedules it, and it is often the highest-value thing in the room. How to ask.
  • Check any doctor's board certification free, in a minute. Which doctor, and how to check them.
  • If getting them there at all is the fight, start there instead. First: getting them there.

You get fifteen minutes, months apart, and you're the only witness who's seen everything. This page turns what you know into what the doctor can use. Print it, fill it in the waiting room.

First: getting them there at all

Half of doctor-visit prep is a person who says there's nothing wrong with them. That refusal is fear wearing armor, and it answers to gentleness, not evidence. The ways in, kindest first:

Which doctor: and how to check any of them

Most families never choose. They get whoever the referral landed on, and then wonder for years whether that was the right person. You are allowed to check, and allowed to change. Two of the checks below are free and take about ten minutes.

Who actually knows dementia. The regular doctor can start the workup and manage most of it, and a good one is worth more than a distant specialist. When you want more depth, the names to ask for are a neurologist, a geriatrician, or a geriatric psychiatrist. That last one is the specialist for the hard behavior and mood problems, and the one families least often hear about. The deepest bench in the country is an NIA-funded Alzheimer's Disease Research Center: the National Institute on Aging funds these at major medical centers, and they help with diagnosis and ongoing management, not only research. The directory is public, state by state, with a phone number for each. If your state has one, it is worth the drive at least once. If you don't know where to start, the free Alzheimer's Association helpline, 1-800-272-3900, answered around the clock, will help you find what's near you, and the resources page lists the local doors state by state.

The two free checks, on any doctor, before or after you see them:

What to ask a doctor you're considering, in the first visit, out loud:

How many people with dementia are you caring for right now? Who do you call when you're not sure? And if I have a question between visits, what actually happens?

The answers tell you more than any credential. A doctor who sees dementia weekly, has someone to consult, and has a real path for between-visit questions will serve you better than a famous name with a six-month waiting list.

The same five questions, whoever they are. Somewhere along the way you may be offered something outside the usual track: a functional-medicine or integrative clinic, a brand-name program, a specialist who works differently. The pull is easy to understand. Conventional care often hands a family a diagnosis, a short prescription and a follow-up in six months. That can feel like being sent home to watch. Ninety minutes of someone asking about sleep and diet and stress answers a real hunger. Wanting that is not gullible. Much of what such clinics emphasize (blood pressure, sleep, hearing, movement, staying connected) is the same evidence-backed ground this site already recommends, which also means you can have that part for free.

And the part that is not established, said as plainly as the part that is. No published evidence shows that a branded protocol, a long supplement stack, or repeated specialty testing reverses or halts dementia. The best-known "reversal" program has a peer-reviewed pilot behind it, but still no peer-reviewed controlled trial (the detail, with costs and what is free about it). Hold that next to the honest status of conventional treatment, which this page states two sections down. There is no cure. The symptom drugs lose effectiveness as the disease advances. The anti-amyloid infusions slow decline in early disease, at the cost of a real risk of brain swelling.

So the useful move isn't sorting practitioners into trusted and suspect camps. It's asking everyone the same five things, the neurologist and the clinic you found online alike:

A practitioner of any kind who takes those five without bristling has told you something good. The bristling is itself the answer.

Two lines that hold no matter who is asking. Nobody except the prescribing doctor should be telling you to stop or reduce a prescribed medicine. And no plan of any kind, conventional or otherwise, is worth money you need for care, rent, or your own health. Everything else is a judgment call that belongs to your family.

Reasons to change doctors, none of which are rude:

Second opinions are ordinary medicine, not an insult, and they're usually covered; you do not need permission and you do not need to explain yourself.

Bring these three things

How to describe changes so they land

Questions worth your fifteen minutes

The medicine review nobody schedules

Of everything on this page, this is the item most likely to hand you back a better week. Some medicines commonly prescribed to older people worsen confusion, and their effects stack: three mild ones together can look exactly like the disease advancing. The list below is not a list of bad drugs, and nothing here is a reason to stop anything. It is a list of things worth asking about, because nobody reviews the whole bottle collection unless a family asks.

Never stop or reduce any of these on your own. Several cause serious withdrawal if stopped abruptly, and some are exactly right for the person taking them. The move is a conversation and a plan, not a decision at the kitchen table.

How to ask for the review. Bring the bag of bottles (the "brown-bag review"), and say it in one sentence:

Could we go through every one of these and ask which are still earning their place? I'm most worried about anything that could be adding to the confusion.

Your pharmacist can do this too, often faster and at no charge, and they see every prescriber's list at once, which the doctors usually don't. If your person has Medicare Part D and several chronic conditions, ask the plan whether they qualify for Medication Therapy Management: a free, formal version of exactly this review. Then bring what you learn back to the prescriber, because only the prescriber changes the prescription.

One thing to raise in the same conversation, from the other direction: untreated pain also looks like agitation. Chapter 4 covers the behavior-is-a-message detective work, and scheduled plain acetaminophen is often the question worth asking before anything sedating.

The dementia medicines themselves: what they do and don't

The section above is about medicines that may be making things worse. This one is about the drugs offered for the dementia, because families are handed a prescription at a fifteen-minute appointment and rarely told plainly what to expect. Start with the sentence the National Institute on Aging puts at the top of its own page: there is currently no intervention that cures Alzheimer's. Everything below is worth understanding anyway, and understanding it is what stops both false hope and the quiet despair of thinking nothing can be done.

Two different kinds of drug get confused constantly, so separate them first.

1. The symptom medicines, the ones most families are actually offered. Cholinesterase inhibitors (donepezil, rivastigmine, galantamine) slow the breakdown of acetylcholine, a brain chemical used in memory and thinking; they're prescribed across mild, moderate and, for some, severe stages. Memantine works differently, on glutamate, and is prescribed for moderate to severe disease. The two types can be taken together.

2. The anti-amyloid infusions (lecanemab, donanemab), which are the ones in the news. These target the amyloid protein itself, and they are only for mild cognitive impairment or mild Alzheimer's. So for most families reading this site they are not on the table, and being told that early saves a painful chase. What they do is slow the rate of decline in early disease. They do not reverse it and they do not restore what is gone.

One overlap worth naming, because it looks like a contradiction with the section above: brexpiprazole, an atypical antipsychotic, is FDA-approved specifically for agitation in Alzheimer's. Approved does not mean first, and its listed side effects include stroke. The order the rest of this site teaches still holds: hunt the cause (pain, infection, a full bladder, constipation, the room, the hour), then the non-drug moves, then this conversation with a doctor who knows the whole picture.

The three questions that make any of this useful, whichever drug is on the table:

What are we hoping this does, and how will we know in three months whether it did? What are we watching for? And what would make us stop it?

A prescription that nobody ever re-evaluates is how people end up on drugs long past the point of benefit. Put the answer on your changes list, and put the review date in the calendar the day it starts.

Your changes list

Cut the phone tag: five calls that pay for themselves forever

None of these are urgent. All five save you hours of hold music later. Make them once and stop thinking about them.

One more thing

Ask for yourself too. One sentence: "And I'm the full-time caregiver. What support exists for me?" Doctors know about respite programs, social workers, and caregiver clinics that nobody thinks to mention until asked.